Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.

Chrzanowski J, Nowicka J, Koralewski R, Joachimiak L, Gzik A, Borek B, Brzezinska J, Kusmirek D, Olejniczak S, Matyszewski K, Mazur M, Olczak J, Glatt S, Grudnik P, Wilk P, Muchowicz A, Kikulska A, Gluchowska KM, Drzewicka K, Belczyk-Ciesielska A, Wachowska M, Sipak-Bujanowicz Z, Mulewski K, Tkaczyk A, Rejczak T, Golebiowski A, Zaslona Z, Blaszczyk R

Open source

DOI
10.1021/acs.jmedchem.6c00407
Published
2026 May 28
Container
Journal of medicinal chemistry
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1021/acs.jmedchem.6c00407,
  title = {Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.},
  author = {Chrzanowski J and Nowicka J and Koralewski R and Joachimiak L and Gzik A and Borek B and Brzezinska J and Kusmirek D and Olejniczak S and Matyszewski K and Mazur M and Olczak J and Glatt S and Grudnik P and Wilk P and Muchowicz A and Kikulska A and Gluchowska KM and Drzewicka K and Belczyk-Ciesielska A and Wachowska M and Sipak-Bujanowicz Z and Mulewski K and Tkaczyk A and Rejczak T and Golebiowski A and Zaslona Z and Blaszczyk R},
  year = {2026},
  journal = {Journal of medicinal chemistry},
  doi = {10.1021/acs.jmedchem.6c00407},
  url = {https://doi.org/10.1021/acs.jmedchem.6c00407}
}

RIS

TY  - JOUR
TI  - Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.
AU  - Chrzanowski J
AU  - Nowicka J
AU  - Koralewski R
AU  - Joachimiak L
AU  - Gzik A
AU  - Borek B
AU  - Brzezinska J
AU  - Kusmirek D
AU  - Olejniczak S
AU  - Matyszewski K
AU  - Mazur M
AU  - Olczak J
AU  - Glatt S
AU  - Grudnik P
AU  - Wilk P
AU  - Muchowicz A
AU  - Kikulska A
AU  - Gluchowska KM
AU  - Drzewicka K
AU  - Belczyk-Ciesielska A
AU  - Wachowska M
AU  - Sipak-Bujanowicz Z
AU  - Mulewski K
AU  - Tkaczyk A
AU  - Rejczak T
AU  - Golebiowski A
AU  - Zaslona Z
AU  - Blaszczyk R
PY  - 2026
JO  - Journal of medicinal chemistry
DO  - 10.1021/acs.jmedchem.6c00407
UR  - https://doi.org/10.1021/acs.jmedchem.6c00407
ER  - 

APA

J, C., J, N., R, K., L, J., A, G., B, B., J, B., D, K., S, O., K, M., M, M., J, O., S, G., P, G., P, W., A, M., A, K., KM, G., K, D., A, B., M, W., Z, S., K, M., A, T., T, R., A, G., Z, Z., & R, B. (2026). Structure-Guided Discovery of OAT-4828 as Potent, Selective, and Orally Bioavailable USP7 Inhibitor with In Vivo Antileukemic Activity.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00407

Source records